Nissenson Allen
- SEC CIK
- 0001441889
No open-market purchases or sales filed in the past year.
Current role at each company
- ELTX Elicio Therapeutics, Inc.Directoras of Sep 2, 2026
- RMTI Rockwell Medical, Inc.Directoras of Jul 6, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Nissenson Allen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ELTX Elicio Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 23, 2022 (view filing) | May 19-20 | 4 days | Nissenson AllenDirector | PPurchase | +9.38K | $1.16 | +$10.9K | New position9.38K after | 2 lots |